1095 related articles for article (PubMed ID: 28747266)
1. IgG4, complement, and the mechanisms of blister formation in pemphigus and bullous pemphigoid.
Dainichi T; Chow Z; Kabashima K
J Dermatol Sci; 2017 Dec; 88(3):265-270. PubMed ID: 28747266
[TBL] [Abstract][Full Text] [Related]
2. Comparison of IgG subclasses and complement binding activity of autoantibodies from patients with bullous pemphigoid and pemphigus.
Brooks WS; Lee YY; Abell E; Deng JS
J Clin Lab Anal; 1989; 3(5):307-11. PubMed ID: 2681622
[TBL] [Abstract][Full Text] [Related]
3. Human IgG1 monoclonal antibody against human collagen 17 noncollagenous 16A domain induces blisters via complement activation in experimental bullous pemphigoid model.
Li Q; Ujiie H; Shibaki A; Wang G; Moriuchi R; Qiao HJ; Morioka H; Shinkuma S; Natsuga K; Long HA; Nishie W; Shimizu H
J Immunol; 2010 Dec; 185(12):7746-55. PubMed ID: 21076071
[TBL] [Abstract][Full Text] [Related]
4. Bullous pemphigoid autoantibodies directly induce blister formation without complement activation.
Ujiie H; Sasaoka T; Izumi K; Nishie W; Shinkuma S; Natsuga K; Nakamura H; Shibaki A; Shimizu H
J Immunol; 2014 Nov; 193(9):4415-28. PubMed ID: 25261486
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and classification of pemphigus and bullous pemphigoid.
Kershenovich R; Hodak E; Mimouni D
Autoimmun Rev; 2014; 13(4-5):477-81. PubMed ID: 24424192
[TBL] [Abstract][Full Text] [Related]
6. Changes in the autoimmune blistering response: a clinical and immunopathological shift from pemphigus foliaceus to bullous pemphigoid.
Maeda JY; Moura AK; Maruta CW; Santi CG; Prisayanh PS; Aoki V
Clin Exp Dermatol; 2006 Sep; 31(5):653-5. PubMed ID: 16901304
[TBL] [Abstract][Full Text] [Related]
7. Immunopathologic mechanisms in pemphigus and bullous pemphigoid.
Jordon RE; Kawana S; Fritz KA
J Invest Dermatol; 1985 Jul; 85(1 Suppl):72s-78s. PubMed ID: 3891883
[TBL] [Abstract][Full Text] [Related]
8. A case of bullous pemphigoid with antibodies against intercellular 130 kd antigen.
Takahashi H; Wada T; Matsuo S; Iwatsuki K; Iizuka H
J Dermatol; 1995 Aug; 22(8):576-81. PubMed ID: 7560455
[TBL] [Abstract][Full Text] [Related]
9. IgG4 autoantibodies are inhibitory in the autoimmune disease bullous pemphigoid.
Zuo Y; Evangelista F; Culton D; Guilabert A; Lin L; Li N; Diaz L; Liu Z
J Autoimmun; 2016 Sep; 73():111-9. PubMed ID: 27377454
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of Disease: Pemphigus and Bullous Pemphigoid.
Hammers CM; Stanley JR
Annu Rev Pathol; 2016 May; 11():175-97. PubMed ID: 26907530
[TBL] [Abstract][Full Text] [Related]
11. The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases.
Sitaru C; Mihai S; Zillikens D
Arch Dermatol Res; 2007 Apr; 299(1):1-8. PubMed ID: 17277959
[TBL] [Abstract][Full Text] [Related]
12. Bullous pemphigoid: role of complement and mechanisms for blister formation within the lamina lucida.
Iwata H; Kitajima Y
Exp Dermatol; 2013 Jun; 22(6):381-5. PubMed ID: 23651418
[TBL] [Abstract][Full Text] [Related]
13. Bullous pemphigoid suggestive of complement-independent blister formation with anti-BP180 IgG4 autoantibodies.
Dainichi T; Nishie W; Yamagami Y; Sonobe H; Ujiie H; Kaku Y; Kabashima K
Br J Dermatol; 2016 Jul; 175(1):187-90. PubMed ID: 26799363
[No Abstract] [Full Text] [Related]
14. Subclass characteristics of IgG autoantibodies in bullous pemphigoid and pemphigus.
Shirakata Y; Shiraishi S; Sayama K; Miki Y
J Dermatol; 1990 Nov; 17(11):661-6. PubMed ID: 2094743
[TBL] [Abstract][Full Text] [Related]
15. Transition from pemphigus foliaceus to bullous pemphigoid: intermolecular B-cell epitope spreading without IgG subclass shifting.
Recke A; Rose C; Schmidt E; Bröcker EB; Zillikens D; Sitaru C
J Am Acad Dermatol; 2009 Aug; 61(2):333-6. PubMed ID: 19615544
[TBL] [Abstract][Full Text] [Related]
16. Pemphigus and bullous pemphigoid.
Nousari HC; Anhalt GJ
Lancet; 1999 Aug; 354(9179):667-72. PubMed ID: 10466686
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of immunologic injury. Pemphigus and bullous pemphigoid.
Anhalt GJ; Patel H; Diaz LA
Arch Dermatol; 1983 Sep; 119(9):711-4. PubMed ID: 6351756
[No Abstract] [Full Text] [Related]
18. Complement-independent blistering mechanisms in bullous pemphigoid.
Iwata H; Ujiie H
Exp Dermatol; 2017 Dec; 26(12):1235-1239. PubMed ID: 28418613
[TBL] [Abstract][Full Text] [Related]
19. The desmosome and hemidesmosome in cutaneous autoimmunity.
Lin MS; Mascaró JM; Liu Z; España A; Diaz LA
Clin Exp Immunol; 1997 Jan; 107 Suppl 1():9-15. PubMed ID: 9020929
[TBL] [Abstract][Full Text] [Related]
20. Coexistence of pemphigus foliaceus and bullous pemphigoid. Demonstration of autoantibodies that bind to both the pemphigus foliaceus antigen complex and the bullous pemphigoid antigen.
Korman NJ; Stanley JR; Woodley DT
Arch Dermatol; 1991 Mar; 127(3):387-90. PubMed ID: 1998370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
